{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T06:31:54Z","timestamp":1648967514036},"reference-count":5,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.vaccine.2007.09.029","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T11:31:00Z","timestamp":1191324660000},"page":"8101","source":"Crossref","is-referenced-by-count":2,"title":["Letter to the Editor"],"prefix":"10.1016","volume":"25","author":[{"given":"Penina","family":"Haber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Slade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Iskander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.029_bib1","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2007.03.053","article-title":"Guillain-Barr\u00e9 Syndrome after vaccination in United States A report from the CDC\/FDA Vaccine Adverse Event Reporting System","volume":"25","author":"Souayah","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.029_bib2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/S0264-410X(99)00132-2","article-title":"An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system","volume":"17","author":"Singleton","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.09.029_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the vaccine adverse event reporting system","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect J"},{"issue":"20","key":"10.1016\/j.vaccine.2007.09.029_bib4","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","article-title":"Guillain-Barr\u00e9 Syndrome (GBS) following influenza vaccine","volume":"292","author":"Haber","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.029_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barr\u00e9 Syndrome: epidemiology, pathology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T20:28:01Z","timestamp":1546547281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":5,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0264410X07010456"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.029","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}